Atherectomy Followed by a Drug Coated Balloon to Treat Peripheral Arterial Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 121 participants.
Also called NCT01366482
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 121 participants
- Sponsor
- Registry
-
NCT01366482
-
- Other papers using this trial's data
- Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium
- Registry status
- Completed
Technical summary
Registry record NCT01366482. Randomized; double masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2014-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Atherectomy Followed by a Drug Coated Balloon to Treat Peripheral Arterial Disease
- Acronym
- DEFINITIVE AR
- Condition
- Peripheral Arterial Disease
- Condition
- Claudication
- Intervention (Device)
- Cotavance Drug-Eluting Balloon
- Intervention (Device)
- TurboHawk/SilverHawk + Cotavance Drug-Eluting Balloon
- Intervention (Device)
- TurboHawk/SilverHawk + Cotavance Drug-Eluting Balloon
- Lead sponsor
- Medtronic Endovascular
- Collaborator
- MEDRAD, Inc.
Record details
- Record id
cardio:ct-nct01366482- Content hash
4d5ec0ac42c3cdb948909e9f6794476452319b9955064962d1ba5ba2f342f262